Invesco Dorsey Wright Healthcare Momentum ETF Rating → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free PTH Stock Alerts $41.92 +0.17 (+0.41%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOptions ChainOwnershipRatingsTrendsStock AnalysisChartHoldingsOptions ChainOwnershipRatingsTrends Invesco Dorsey Wright Healthcare Momentum ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PTH Aggregate RatingModerate Buy2.80Holdings in PTH have an aggregate rating of Moderate Buy based on 424 analyst ratings issued in the past year covering 49 companies (94.4% of the portfolio).PTH Aggregate Price Target$52.1524.40% UpsideHigh Prediction$68.22Average Prediction$52.15Low Prediction$34.95Holdings in PTH have an aggregate price target of $52.15 and a range of $34.95 to $68.22 covering 49 companies (94.4% of the portfolio).PTH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Dorsey Wright Healthcare Momentum ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 PTH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.54%LLYEli Lilly and Company$820.34+0.6%5 of 5 stars2.84$769.53 -6.2%19Insider Selling4.67%IDXXIDEXX Laboratories$496.95-0.6%4 of 5 stars2.67$580.38 16.8%9Positive News4.43%MEDPMedpace$386.34+0.2%5 of 5 stars2.86$443.14 14.7%7Analyst ForecastInsider Selling4.19%THCTenet Healthcare$135.22+1.5%4 of 5 stars3.06$120.41 -11.0%18Analyst ForecastShort Interest ↑News Coverage3.37%NTRANatera$106.53-3.3%2 of 5 stars3.00$98.47 -7.6%15Insider SellingNews Coverage2.88%REGNRegeneron Pharmaceuticals$980.16+1.1%4 of 5 stars2.76$989.36 0.9%21Insider SellingHigh Trading Volume2.78%DVADaVita$147.120.0%3 of 5 stars2.33$144.67 -1.7%3Analyst UpgradePositive News2.74%RNAAvidity Biosciences$26.86-0.7%2 of 5 stars3.00$41.33 53.9%6Positive NewsGap Down2.62%IBRXImmunityBio$6.42-2.9%0 of 5 stars2.00$6.00 -6.5%1Positive News2.61%CORCencora$226.57+2.7%4 of 5 stars2.70$233.90 3.2%10Insider BuyingHigh Trading Volume2.50%VERAVera Therapeutics$37.99+2.8%1 of 5 stars3.00$42.86 12.8%8Analyst Forecast2.40%ABBVAbbVie$161.24+3.2%4 of 5 stars2.79$176.14 9.2%14Short Interest ↑Analyst RevisionHigh Trading Volume2.28%MOHMolina Healthcare$314.58+2.8%5 of 5 stars2.58$407.45 29.5%12Analyst ForecastNews CoverageHigh Trading Volume2.28%ARQTArcutis Biotherapeutics$8.36-3.5%1 of 5 stars2.75$25.38 203.5%8Insider SellingNews Coverage2.26%MDGLMadrigal Pharmaceuticals$236.16+4.7%5 of 5 stars2.73$345.09 46.1%11Positive News2.12%DYNDyne Therapeutics$31.88+2.2%4 of 5 stars3.11$40.78 27.9%9Analyst Revision2.08%MRUSMerus$53.24-7.1%2 of 5 stars3.00$63.80 19.8%12Analyst ForecastAnalyst Revision2.02%IDYAIDEAYA Biosciences$36.55+2.1%3 of 5 stars3.00$46.80 28.0%12Insider SellingNews Coverage1.99%RDNTRadNet$58.64-0.4%3 of 5 stars2.75$57.25 -2.4%4Positive News1.94%KRYSKrystal Biotech$160.05-1.0%4 of 5 stars3.00$177.63 11.0%9Positive News1.79%LQDALiquidia$12.87+0.1%3 of 5 stars2.60$21.00 63.2%5Positive NewsHigh Trading Volume1.78%HIMSHims & Hers Health$19.42-4.7%2 of 5 stars2.53$15.69 -19.2%15Short Interest ↑1.75%PCVXVaxcyte$70.27+0.1%1 of 5 stars3.00$78.50 11.7%4Insider SellingPositive News1.74%BHVNBiohaven$35.10-0.4%3 of 5 stars3.00$51.63 47.1%8Analyst ForecastInsider BuyingNews Coverage1.73%ENSGThe Ensign Group$121.24+2.3%4 of 5 stars2.80$124.60 2.8%5News CoveragePositive NewsHigh Trading Volume1.67%GKOSGlaukos$112.72+1.8%4 of 5 stars2.82$109.55 -2.8%11Short Interest ↓1.63%ADMAADMA Biologics$9.55+0.7%2 of 5 stars3.25$10.50 9.9%4Positive News1.55%SYRESpyre Therapeutics$34.95+2.6%0 of 5 stars3.00$43.17 23.5%81.49%CRNXCrinetics Pharmaceuticals$44.41-2.1%4 of 5 stars2.92$60.92 37.2%12Insider Selling1.48%VCELVericel$47.70-1.0%0 of 5 stars3.00$46.80 -1.9%61.48%BPMCBlueprint Medicines$105.56-0.8%1 of 5 stars2.53$103.94 -1.5%17Positive News1.45%APGEApogee Therapeutics$45.64-1.6%3 of 5 stars3.00$73.00 59.9%8Positive News1.39%OCULOcular Therapeutix$5.70-1.7%4 of 5 stars2.83$15.17 166.1%6Analyst ForecastGap Up1.38%KURAKura Oncology$20.61-0.4%3 of 5 stars2.86$27.94 35.6%7Positive News1.35%NUVLNuvalent$65.62-1.3%2 of 5 stars2.90$90.78 38.3%10Insider SellingPositive NewsHigh Trading Volume1.26%ITCIIntra-Cellular Therapies$67.24+2.4%5 of 5 stars2.90$90.17 34.1%10Short Interest ↑Positive News1.19%UFPTUFP Technologies$260.36-0.3%2 of 5 stars2.50$238.50 -8.4%2News CoveragePositive News1.13%SWTXSpringWorks Therapeutics$41.46-2.7%1 of 5 stars3.00$68.83 66.0%6Analyst Forecast1.00%SILKSilk Road Medical$21.74+5.6%2 of 5 stars2.18$20.10 -7.5%11Positive NewsHigh Trading Volume0.98%LMATLeMaitre Vascular$78.88+0.1%4 of 5 stars2.89$77.57 -1.7%9Analyst ForecastAnalyst Revision0.95%FATEFate Therapeutics$3.68+6.7%5 of 5 stars2.14$6.58 78.9%14Short Interest ↓0.92%BKDBrookdale Senior Living$6.71+0.9%3 of 5 stars2.50$7.50 11.8%2Short Interest ↓0.87%LFMDLifeMD$8.25-2.9%2 of 5 stars3.00$12.60 52.7%5Positive News0.86%KROSKeros Therapeutics$46.87+1.2%2 of 5 stars3.00$86.00 83.5%7News CoveragePositive News0.84%PRAXPraxis Precision Medicines$47.46+4.4%2 of 5 stars2.80$105.80 122.9%5High Trading Volume0.81%ANIPANI Pharmaceuticals$64.90+2.3%5 of 5 stars3.00$81.00 24.8%4Short Interest ↓Positive News0.77%FULCFulcrum Therapeutics$7.85+2.6%3 of 5 stars3.00$15.57 98.4%7Positive News0.77%EOLSEvolus$12.93+2.5%4 of 5 stars3.00$21.25 64.3%3Positive News0.72%COLLCollegium Pharmaceutical$33.14+2.2%3 of 5 stars2.20$39.00 17.7%5Insider Selling This page (NASDAQ:PTH) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Dorsey Wright Healthcare Momentum ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
